Interesting investment. On paper this looks like a winner, but...

Interesting investment. On paper this looks like a winner, but it’s having trouble getting out of the starting gate. Floated in 2014 and hit the ground running. Receipts came to over $400 per Q. Faded over the next couple of years (not sure why) down to $70 of receipts in 2016. Been bumping on the bottom ever since. Started to move upward over the last couple of Q’s, but stalled last Q with only $211 in receipts. 
Has a cash spend of over $2 mil per Q so needs shareholders to top up every 3 rd Q or so. Govt R & D grants pulls it out of the bog now and then. All the studies point to Orthocell having a great product but just can’t get the sales.  Changed the focus to dental a couple of years ago. Maybe a more receptive market. Thers’ been a lot of work to build networks over the last two years so maybe ready to turn around. IMO still has at least two CR’s to go before this happens.
Got out of this in 2015 and would like to get back in, need receipts to be consistently over $500 per Q and rising before this happens.